BioSpace News Archive

A new study has identified critical gaps in care for people with Parkinson’s disease in the U.S., including disparities affecting women, people of color and residents of rural areas.

Hospital for Special Surgery and NCH Healthcare System announced that David L. Helfet, MD, renowned HSS orthopedic trauma surgeon, has been appointed Executive Medical Director of HSS at NCH, the collaboration formed to bring high quality orthopedic care to southwest Florida.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, released its corporate sustainability report for fiscal year ended December 31, 2022.

Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, is pleased to announce the closing of the previously announced transaction with Cardinal Health (NYSE: CAH) to merge with Outcomes.

In anticipation of Cord Blood Awareness Month this July, Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, announced the formation of the Be The Match BioTherapies Cord Blood Bank Alliance.

This event will be webcast live and a replay will be available on 3M’s Investor Relations website.

Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. (“Nexcella”, “Company”, “We” or “Us”), today announced the completion of its initial CAR-T NXC-201 engineering batch at its U.S. manufacturing site.

Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), today announced the completion of its initial CAR-T NXC-201 engineering batch at its U.S. manufacturing site. This represents an important step forward in the planned U.S. expansion of the Company’s ongoing Phase 1b/2a NEXICART-1 (NCT04720313) study of its novel BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201.

Express Scripts announced that as part of its commitment to driving greater affordability for clients and people living with inflammatory conditions, it will add three additional biosimilars to its National Preferred Formulary.

Employees once again rate the company as a top workplace Agilent Technologies Inc. announced the company has achieved certification as a Great Place to Work®.